Bon usage des antidépresseurs ISRS durant la grossesse – le défi de l'évaluation de la balance bénéfice-risque
| Autor: | Weisskopf, Etienne, Fischer Fumeaux, Céline J, Bickle Graz, Myriam, Harari, Mathild Morisod, Epiney, Manuela, Borradori Tolsa, Cristina, Rouiller-Cornu, Sylvie, Tolsa, Jean-François, Eap, Chin Bin, Vial, Yvan, Csajka, Chantal, Panchaud-Monnat, Alice |
|---|---|
| Jazyk: | francouzština |
| Rok vydání: | 2016 |
| Předmět: |
Antidepressive Agents/adverse effects/therapeutic use
ddc:615 ddc:618 digestive oral and skin physiology Depressive Disorder/complications/drug therapy Serotonin Uptake Inhibitors/adverse effects/therapeutic use behavioral disciplines and activities Risk Assessment Pregnancy mental disorders Humans Female Pregnancy Complications/chemically induced/drug therapy/psychology Practice Patterns Physicians' |
| Zdroj: | Revue médicale suisse, Vol. 12, No 510 (2016) pp. 561-6 |
| ISSN: | 1660-9379 |
| Popis: | Studies report that between 6 and 13% of women experience symptoms of depression during pregnancy and the postpartum period. The abundant data available make selective serotonin reuptake inhibitors (SSRIs) the first line treatment in pregnancy when a pharmacological treatment is required. Risks associated with the use of SSRIs during pregnancy are limited (moderate effect size) and are often not distinguishable from those inherent to the mother's disease. Yet, several questions regarding the SSRI safety profile for the unborn child are still under debate or require additional epidemiological data. The decision of SSRI use during pregnancy needs an individual evaluation of the risk-benefit balance. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|